Skip to main content

Advertisement

Log in

Carboplatin and vinorelbine in advanced non-small-cell lung cancer

  • CLINICAL TRIAL REPORT
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

 A total of 32 patients with advanced non-small-cell lung cancer were treated with carboplatin (350 mg/m2, day 1) and vinorelbine (days 1 and 8) every 28 days. A response rate of 28% (95% confidence limits 12.5 – 43.7%) was observed. The activity of this combination was demonstrated in an outpatient setting with acceptable toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 6 July 1995 / Accepted: 19 October 1995

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pronzato, P., Ghio, E., Losardo, P. et al. Carboplatin and vinorelbine in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 37, 610–612 (1996). https://doi.org/10.1007/s002800050436

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002800050436

Navigation